Detection of immunoglobulin M and G antibodies against cytomegalovirus early and late antigens by enzyme-linked immunosorbent assay
- 1 October 1984
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 20 (4) , 763-771
- https://doi.org/10.1128/jcm.20.4.763-771.1984
Abstract
A sensitive and reproducible enzyme-linked immunosorbent assay (ELISA) is described for the detection of immunoglobulin M and antibodies with specifity for human cytomegalovirus (CMV) early (CMV-EA) and late (CMV-LA) antigens. The emphasis is on the production of high-quality CMV antigens, CMV-EA and CMV-LA separately, and conditions for their application in the ELISA. The induction of CMV-EA and -LA in infected cell extracts was studied in detail by using human sera with defined antibody specificity for CMV-EA and CMV-LA. This resulted in the development of a simple whole cell extraction procedure that provided a high yield of CMV antigens with reproducible antigen quality. The antigens were specific for the detection of anti-CMV antibodies. The influence of autoantibodies on the determination of CMV-specific antibodies was investigated. Parallel analysis of 322 human sera by indirect immunofluorescence and ELISA showed a high correlation between both assays (r = 0.9674 for CMV-EA and 0.9362 for CMV-LA). Antibody titers determined by ELISA were equal to (for CMV-EA) or slightly higher (for CMV-LA) that those determined by immunofluorescence but significantly higher (20- to 5,120-fold) than those determined by complement fixation. From 191 sera positive by ELISA (titer greater than or equal to 40) 4 (2.1%) were negative by immunofluorescence (titer less than 40), and from 61 ELISA-positive sera 12 (19.6%) were negative (titer less than 8) when tested by complement fixation. Consequently, ELISA for CMV may prove to be more reliable for the selection of CMV-seronegative blood donors than these other methods. The use of high-quality antigens allows more economic handling of large-scale serum determinations. Possibilities for further automation are discussed.This publication has 39 references indexed in Scilit:
- The detection of antibodies to cytomegalovirus in the sera of renal transplant patients by an igm antibody capture assayJournal of Medical Virology, 1983
- Human Fibroblasts, a Convenient Nuclear Substrate for Detection of Anti-Nuclear Antibodies Including Anti-Centromere AntibodiesScandinavian Journal of Rheumatology, 1983
- Infection with Cytomegalovirus During Pregnancy: Specific IgM Antibodies as a Marker of Recent Primary InfectionThe Journal of Infectious Diseases, 1982
- Virus-Specific IgG and IgM Antibodies in Normal and Immunocompromised Subjects Infected with CytomegalovirusThe Journal of Infectious Diseases, 1982
- False RIA IgM titres to herpes simplex virus and cytomegalovirus: Factors causing them, and their absorption by protein A-sepharose/IgG-protein A-sepharoseJournal of Medical Virology, 1982
- Assessment of human cytomegalovirus antibody detection techniquesArchiv für die gesamte Virusforschung, 1980
- ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA) FOR DETERMINATION OF IgG ANTIBODIES TO HUMAN CYTOMEGALOVIRUSActa Pathologica Microbiologica Scandinavica Section B Microbiology, 1980
- Determination of iga antibodies to human cytomegalovirus by enzyme‐linked immunosorbent assay (elisa)Journal of Medical Virology, 1980
- Inhibition of Cytomegalovirus Late Antigens by PhosphonoformateIntervirology, 1979
- Rapid detection of IgG and IgM antibodies for cytomegalovirus by the enzyme linked immunosorbent assay (ELISA)Archiv für die gesamte Virusforschung, 1978